人类癌症中的上皮膜蛋白1:潜在的诊断生物标志物和治疗点
Yuxin Xie1, Feng Wu1, Zhe Chen1
1Department of Radiological Medicine, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, 400016, China.
Biomarkers in medicine
|October 29, 2024
概括
表皮膜蛋白1 (EMP1) 在癌症中充当瘤基因或瘤抑制剂,影响转移和进展. 了解EMP1的理解
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 表皮膜蛋白1 (EMP1) 是一种小型的疏水性膜蛋白.
- EMP1在各种瘤组织中表现出异常表达.
- EMP1影响关键的细胞行为,如增殖,分化和迁移.
研究的目的:
- 提供EMP1在癌症中的双重作用 (瘤基因/瘤抑制剂) 的最新概述.
- 总结EMP1的上游调节器和下游目标基因.
- 巩固目前关于EMP1在恶性瘤发展中的作用的知识.
主要方法:
- 对EMP1.1现有的文献进行系统审查.
- 分析EMP1在癌症途径中的作用.
- 调查EMP1的功能机制.
主要成果:
- 在许多癌症中,EMP1的表达被改变了.
- EMP1调节癌细胞的增殖,迁移和分化.
- EMP1的功能取决于上下文,作为一种瘤基因或瘤抑制剂.
结论:
- EMP1在瘤进展和转移中发挥着重要作用.
- 在瘤学中,EMP1具有作为诊断生物标志物和治疗点的潜力.
- 对EMP1的监管网络进行进一步研究是有必要的.
相关概念视频
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


